Large-scale testing (Phase 3)Study completedNCT05172050
What this trial is testing
Multicenter Double Blind, Parallel-group Phase 2/3 Trial, to Study Raloxifene in Adult COVID-19 Patients.
Who this might be right for
SARS CoV 2 Infection
Dompé Farmaceutici S.p.A 61